IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding IDEAYA Biosciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 204 | 4 | 224 | +24 |
| Shares | 96.8M | 54.1K | 94.1M | −2.68M (−2.8%) |
| Value | $2.04B | $1.14M | $2.56B | +$525.8M (+25.9%) |
4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (21)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AXA S.A. | 324,543 | $6.82M |
| Voloridge Investment Management, LLC | 283,811 | $5.97M |
| Two Sigma Advisers, LP | 266,600 | $5.60M |
| Algert Global LLC | 253,080 | $5.32M |
| Foresite Capital Management VI LLC | 144,468 | $3.04M |
| D. E. Shaw & Co., Inc. | 98,153 | $2.06M |
| Aquatic Capital Management LLC | 85,178 | $1.79M |
| Nebula Research & Development LLC | 60,767 | $1.28M |
| UBS Oconnor LLC | 51,600 | $1.08M |
| Twinbeech Capital LP | 34,557 | $726.4K |
| Skandinaviska Enskilda Banken AB (publ) | 32,544 | $684.1K |
| Engineers Gate Manager LP | 28,692 | $603.1K |
| Two Sigma Securities, LLC | 22,022 | $462.9K |
| Mount Yale Investment Advisors, LLC | 2,893 | $60.8K |
| South State Corp. | 500 | $10.5K |
| Caitong International Asset Management Co., Ltd | 193 | $4.06K |
| Fourth Dimension Wealth, LLC | 150 | $3.15K |
| Meeder Asset Management Inc | 136 | $2.86K |
| Raymond James Financial Inc | 34 | $715 |
| Bare Financial Services, Inc | 32 | $673 |
| Hughes Financial Services, LLC | 24 | $567 |
Not filed for Q3 2025 yet (4)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 30,589 | $643.0K |
| E Fund Management Co., Ltd. | 12,225 | $257.0K |
| CIBC World Markets Corp | 10,324 | $217.0K |
| First Horizon Advisors, Inc. | 934 | $19.6K |